RESUMO
The majority of urinary tract infections (UTIs) are caused by uropathogenic Escherichia coli (UPEC). Designing a vaccine will certainly reduce the occurrence of infection and antibiotic resistance of the isolates. Antigen 43 (Ag43) and autotransporter H (UpaH) have been associated with the virulence of UPEC. In the present study, the efficacy of different formulations of a hybrid protein composed of Ag43 and UpaH with and without alum and 1,25(OH)2D3 (Vitamin D3) adjuvants were evaluated in mice model. A significant increase in IgG and cellular responses was developed against Ag43::UpaH as compared to the control mice. The addition of alum or a mixture of alum and Vitamin D3 to the protein significantly enhanced the serum IgG responses and tended to remain in a steady state until 6 months. In addition, the mentioned formulations produced significant amounts of IgG1, IL-4, and IL-17 as compared to the fusion protein alone. In addition to the mentioned formulations, the combination of protein with Vitamin D3 also resulted in significantly higher serum IgA and IFN-γ levels as compared to the fusion protein alone. Mice immunized with fusion plus alum and formulation protein admixed with both alum and Vitamin D3 significantly reduced the bacterial load in the bladders and kidneys of mice as compared to the control. In this study, for the first time, the ability of a novel hybrid protein in combination with adjuvants alum and Vitamin D3 was evaluated against UPEC. Our results indicated that fusion Ag43::UpaH admixed with alum and Vitamin D3 could be a promising candidate against UTIs.
Assuntos
Compostos de Alúmen/farmacologia , Colecalciferol/farmacologia , Proteínas de Escherichia coli/imunologia , Proteínas Recombinantes de Fusão/imunologia , Infecções Urinárias/prevenção & controle , Escherichia coli Uropatogênica/imunologia , Fatores de Virulência/imunologia , Adjuvantes Imunológicos/farmacologia , Adjuvantes Imunológicos/uso terapêutico , Compostos de Alúmen/administração & dosagem , Animais , Anticorpos Antibacterianos/sangue , Anticorpos Antibacterianos/urina , Antígenos de Bactérias/imunologia , Carga Bacteriana/efeitos dos fármacos , Carga Bacteriana/imunologia , Vacinas Bacterianas/administração & dosagem , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/isolamento & purificação , Colecalciferol/administração & dosagem , Citocinas/metabolismo , Imunidade Humoral/efeitos dos fármacos , Imunização/métodos , Imunoglobulina G/sangue , Imunoglobulina G/urina , Injeções Intravenosas , Camundongos Endogâmicos BALB C , Mucosa/imunologia , Proteínas Recombinantes de Fusão/administração & dosagem , Proteínas Recombinantes de Fusão/isolamento & purificação , Infecções Urinárias/imunologiaRESUMO
BACKGROUND: The massive number of ingredients in traditional Chinese medicines (TCMs) makes quality control very difficult. The concept of quality markers (Q-marker) was recently proposed to evaluate the quality of TCMs. Xuezhiling tablets (XZL) are widely used for the treatment of hyperlipidemia in China owing to its noticeable effectiveness and mild adverse effects, but there are no proper Q-markers for this Chinese patent medicine. PURPOSE: The aim of the present study was to determine the Q-markers of XZL against hyperlipidemia through an integration of investigations on its lipid-lowering effect, metabolomics, content determination and pharmacokinetics. METHODS: XZL was prepared in accordance with the method described in the Chinese pharmacopoeia (Ch.P.). Hyperlipidemia was induced in rats through the administration of a high-fat diet (HFD). The hypolipidemic effect of XZL was investigated through the detection of the blood levels of total glyceride (TG), total cholesterol (TC), and low density lipoprotein cholesterol (LDL-C). A metabolomics study was conducted to analyze the overall effects of XZL on the regulation of lipid metabolism. The main bioactive compounds of XZL were identified and determined in the XZL preparation and the medicated plasma of hyperlipidemic rats. RESULTS: XZL lowered the levels of TG, TC, and LDL-C through alterations of metabolic patterns. 2,3,5,4'-Tetrahydroxystilbene-2-O-ß-D-glucopyranoside (THSG), chrysophanol-1-O-ß-glucopyranosyl-(1â3)-O-ß-D-glucopyranosy1-(1â6)-O-ß-D-glucopyranosyl-(1â6)-O-ß-D-glucopyranoside (SHJ), cassiaside, rubrofusarin gentiobioside, aurantio-obtusin, chryso-obtusin, and obtusinfolin were identified and determined both in the preparation and the blood of hyperlipidemic rats. CONCLUSION: SHJ, obtusinfolin, THSG, rubrofusarin gentiobioside, and aurantio-obtusin, which are more abundant in the preparation, leading to greater exposure in vivo, were suitable Q-markers to guarantee the medicinal quality of XZL and ensure the clinical effectiveness on hyperlipidemia.
Assuntos
Compostos de Alúmen/farmacologia , Compostos de Alúmen/normas , Biomarcadores/análise , Medicamentos de Ervas Chinesas/farmacologia , Medicamentos de Ervas Chinesas/normas , Hiperlipidemias/tratamento farmacológico , Compostos de Alúmen/análise , Compostos de Alúmen/farmacocinética , Animais , Antraquinonas/análise , LDL-Colesterol/sangue , Dieta Hiperlipídica/efeitos adversos , Medicamentos de Ervas Chinesas/análise , Medicamentos de Ervas Chinesas/farmacocinética , Hiperlipidemias/etiologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Lipídeos/sangue , Masculino , Medicina Tradicional Chinesa/normas , Metabolômica , Controle de Qualidade , Ratos Sprague-Dawley , Comprimidos/análise , Triglicerídeos/sangue , Triterpenos/análiseRESUMO
BACKGROUND: Nowadays, the demand for antibacterial fabrics has increased. White alum is used for oral aphthous ulcers treatment in traditional medicine of Sistan city, Sistan and Baluchistan Province, Iran, and also as a flocculent for water purification. This study is aimed to evaluate the effect of concentration and time on antibacterial activity of white alum on Escherichia coli O157:H7. MATERIALS AND METHODS: 0.25, 0.5, 1 and 2% concentrations of white alum were added to 108 CFU of Escherichia coli O157:H7. Optical Density was recorded for 4 hours. Data obtained were analyzed using Repeated Measure and One-way ANOVA by SPSS. RESULTS: Results revealed the effectiveness of white alum in the growth of the tested bacterium. The white alum was found to be potent against Escherichia coli O157:H7 at a concentration above 1% (p<0.05). Also, its effect is dose and time dependent, as well as other disinfectants. CONCLUSION: A wide variety of natural products has been under scrutiny for their clinical potential, both in terms of prevention and treatment. Strong antibacterial activity of white alum compared with control was shown against tested bacterium. In conclusion, white alum can be used as an inhibitor of bacterial growth, especially for Escherichia coli O157:H7.
Assuntos
Compostos de Alúmen/farmacologia , Produtos Biológicos/farmacologia , Escherichia coli O157/efeitos dos fármacos , Minerais/farmacologia , Escherichia coli O157/crescimento & desenvolvimento , Irã (Geográfico) , Estomatite Aftosa/tratamento farmacológico , Purificação da ÁguaRESUMO
INTRODUCTION: Calcium phosphate was used as an adjuvant in France in diphtheria, tetanus, pertussis and poliomyelitis vaccines. It was later completely substituted by alum salts in the late 80's, but it still remains as an approved adjuvant for the World Health Organization for human vaccination. Area covered: Thus, calcium phosphate is now considered as one of the substances that could replace alum salts in vaccines. The aim of this paper is to draw a review of existing data on calcium phosphate as an adjuvant in order to bring out the strengths and weaknesses for its use on a large scale. Expert commentary: Calcium phosphate is a compound naturally present in the organism, safe and already used in human vaccination. Beyond comparisons with the other adjuvants, calcium phosphate represents a good candidate to replace or to complete alum salts as a vaccine adjuvant.
Assuntos
Adjuvantes Imunológicos/farmacologia , Alumínio/farmacologia , Fosfatos de Cálcio/farmacologia , Adjuvantes Imunológicos/efeitos adversos , Compostos de Alúmen/química , Compostos de Alúmen/farmacologia , Animais , Fosfatos de Cálcio/efeitos adversos , Fosfatos de Cálcio/química , Vacina contra Difteria, Tétano e Coqueluche/química , Vacina contra Difteria, Tétano e Coqueluche/imunologia , Vacina contra Difteria, Tétano e Coqueluche/farmacologia , HumanosRESUMO
Eruption of blue-green algal blooms occurs frequently in eutrophic lakes and fish ponds, with associated unpleasant odor and horrid scums. In the present study, we conducted a pre-test experiment in 3 m(3) outdoor concrete ponds to determine the optimum concentration of aluminum sulfate (alum) required for reduction of the cyanobacterial blooms without negative effect on fish growth. As a consequence, 10 mg L(-1) alum was named as the optimum concentration that was applied in 1000 m(3) earthen fish ponds. Obtained results showed that Secchi disc values significantly increased from 10 to 24 cm after 14 days of alum application. Alum-treated ponds showed a reduction in total phytoplankton counts by 94 and 96% compared to the corresponding controls after 10 and 14 days, respectively. Abundance of blue-green algae in the treated ponds was decreased by 98% compared to the corresponding control after 14 days of alum application. Consequently, dissolved oxygen, pH, total phosphorus, orthophosphate, and chlorophyll "a" content declined significantly. Our study revealed that using 10 mg L(-1) of alum is an effective way to control cyanobacterial blooms in eutrophic waters, especially in fish ponds, without negative effect in water quality.
Assuntos
Compostos de Alúmen/farmacologia , Cianobactérias/crescimento & desenvolvimento , Eutrofização/efeitos dos fármacos , Lagoas/química , Compostos de Alúmen/administração & dosagem , Animais , Clorofila/análogos & derivados , Clorofila/análise , Clorofila A , Peixes/crescimento & desenvolvimento , Fósforo/análise , Fitoplâncton/crescimento & desenvolvimento , Qualidade da ÁguaRESUMO
Aluminum salt (alum) has been widely used for vaccinations as an adjuvant. Alum not only enhances immunogenicity but also induces Th2 cell immune responses. However, the mechanisms of how alum enhances Th2 cell immune responses have been controversial. In an experimental allergic airway inflammation model, in which alum in conjunction with OVA Ag was i.p. injected for immunization, we found that apoptotic cells and inflammatory dendritic cells (iDC) expressing CD300a, an inhibitory immunoreceptor for phosphatidylserine (PS), significantly increased in number in the peritoneal cavity after the immunization. In contrast, apoptotic cells and iDCs were scarcely observed in the peritoneal cavity after injection of OVA alone. In CD300a-deficient mice, eosinophil infiltration in bronchoalveolar lavage fluid, serum IgE levels, and airway hyperreactivity were significantly decreased after immunization with alum plus OVA compared with wild-type mice. In vitro, iDCs purified from CD300a-deficient mice after the immunization induced significantly less IL-4 production from OT-II naive CD4(+) T cells after coculture with OVA Ag. CD300a expressed on iDCs bound PS on apoptotic cells in the peritoneal cavity after injection of OVA plus alum. Blocking CD300a interaction with PS by injection of a neutralizing anti-CD300a Ab resulted in inhibition of the development of allergic airway inflammation. These results suggest that CD300a is involved in alum-induced Th2 skewing.
Assuntos
Adjuvantes Imunológicos/farmacologia , Compostos de Alúmen/farmacologia , Ovalbumina/farmacologia , Receptores Imunológicos/imunologia , Hipersensibilidade Respiratória/imunologia , Células Th2/imunologia , Animais , Anticorpos Neutralizantes/administração & dosagem , Anticorpos Neutralizantes/imunologia , Apoptose/imunologia , Asma/genética , Asma/imunologia , Asma/terapia , Líquido da Lavagem Broncoalveolar/citologia , Líquido da Lavagem Broncoalveolar/imunologia , Células Dendríticas/imunologia , Eosinófilos/imunologia , Imunoglobulina E/sangue , Inflamação/imunologia , Interleucina-4/biossíntese , Ativação Linfocitária/efeitos dos fármacos , Ativação Linfocitária/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Fosfatidilserinas/antagonistas & inibidores , Receptores Imunológicos/biossíntese , Receptores Imunológicos/genética , Hipersensibilidade Respiratória/genética , Hipersensibilidade Respiratória/prevenção & controleRESUMO
Advances in nanotechnology and nanomaterials have facilitated the development of silicon dioxide, or Silica, particles as a promising immunological adjuvant for the generation of novel prophylactic and therapeutic vaccines. In the present study, we have compared the adjuvanting potential of commercially available Silica nanoparticles (initial particles size of 10-20 nm) with that of aluminium hydroxide, or Alum, as well as that of complete and incomplete Freund's adjuvants for the immunisation of BALB/c mice with virus-like particles (VLPs) formed by recombinant full-length Hepatitis B virus core (HBc) protein. The induction of B-cell and T-cell responses was studied after immunisation. Silica nanoparticles were able to adsorb maximally 40% of the added HBc, whereas the adsorption capacity of Alum exceeded 90% at the same VLPs/adjuvant ratio. Both Silica and Alum formed large complexes with HBc VLPs that sedimented rapidly after formulation, as detected by dynamic light scattering, spectrophotometry, and electron microscopy. Both Silica and Alum augmented the humoral response against HBc VLPs to the high anti-HBc level in the case of intraperitoneal immunisation, whereas in subcutaneous immunisation, the Silica-adjuvanted anti-HBc level even exceeded the level adjuvanted by Alum. The adjuvanting of HBc VLPs by Silica resulted in the same typical IgG2a/IgG1 ratios as in the case of the adjuvanting by Alum. The combination of Silica with monophosphoryl lipid A (MPL) led to the same enhancement of the HBc-specific T-cell induction as in the case of the Alum and MPL combination. These findings demonstrate that Silica is not a weaker putative adjuvant than Alum for induction of B-cell and T-cell responses against recombinant HBc VLPs. This finding may have an essential impact on the development of the set of Silica-adjuvanted vaccines based on a long list of HBc-derived virus-like particles as the biological component.
Assuntos
Adjuvantes Imunológicos/farmacologia , Antígenos do Núcleo do Vírus da Hepatite B/farmacologia , Vacinas contra Hepatite B/farmacologia , Vírus da Hepatite B/imunologia , Hepatite B/prevenção & controle , Dióxido de Silício/farmacologia , Adjuvantes Imunológicos/química , Compostos de Alúmen/farmacologia , Animais , Feminino , Adjuvante de Freund/imunologia , Adjuvante de Freund/farmacologia , Hepatite B/imunologia , Antígenos do Núcleo do Vírus da Hepatite B/imunologia , Vacinas contra Hepatite B/imunologia , Imunidade Humoral/efeitos dos fármacos , Imunização , Lipídeo A/análogos & derivados , Lipídeo A/imunologia , Lipídeo A/farmacologia , Lipídeos/imunologia , Lipídeos/farmacologia , Camundongos Endogâmicos BALB C , Nanopartículas/química , Dióxido de Silício/química , Dióxido de Silício/imunologiaRESUMO
Current treatment of hemophilia consists of the administration of recombinant clotting factors, such as factor VIII (FVIII). However, patients with severe hemophilia can mount immune responses targeting therapeutically administered FVIII through inhibitory immunoglobulins that limit treatment efficacy. Induction of immune tolerance to FVIII in hemophilia has been extensively studied but remains an unmet need. We found that nondepleting anti-CD4 monoclonal antibodies (mAbs) are effective in inducing long-term tolerance to FVIII in different strains of hemophilic mice. Tolerance induction was facilitated when anti-CD4 mAbs were administered together with FVIII adsorbed in an adjuvant (alum). The observed state of tolerance was antigen specific, with mice remaining immune competent to respond to different antigens. Importantly, we found that following immunization with FVIII, the primed cells remained susceptible to tolerance induction. Studies with Foxp3-deficient and interleukin 10 (IL-10)-deficient mice demonstrated that the underlying tolerance mechanism is Foxp3 independent but requires IL-10. Our data show that an adjuvant, when administered together with a tolerizing agent such as nondepleting anti-CD4, can facilitate the induction of long-term tolerance to recombinant proteins, possibly not only in hemophilia but also in other diseases that are treated with potentially immunogenic therapeutics.
Assuntos
Adjuvantes Imunológicos/farmacologia , Compostos de Alúmen/farmacologia , Fator VIII/imunologia , Fatores de Transcrição Forkhead/fisiologia , Hemofilia A/tratamento farmacológico , Tolerância Imunológica/efeitos dos fármacos , Interleucina-10/fisiologia , Adjuvantes Imunológicos/administração & dosagem , Compostos de Alúmen/administração & dosagem , Animais , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais/farmacologia , Antígenos CD4/imunologia , Combinação de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Fator VIII/administração & dosagem , Fatores de Transcrição Forkhead/genética , Fatores de Transcrição Forkhead/metabolismo , Hemofilia A/imunologia , Tolerância Imunológica/imunologia , Interleucina-10/genética , Interleucina-10/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Transdução de Sinais/imunologia , Linfócitos T Reguladores/imunologia , Linfócitos T Reguladores/metabolismo , Linfócitos T Reguladores/fisiologiaRESUMO
Alum treatment is a lake restoration technique that is used to address internal phosphorus (P) loading. We evaluated the macroinvertebrate density and P release rates from sediment cores in Spring Lake, Michigan, 5 yr after an alum treatment and compared the findings with conditions before and 1 yr after application. Total macroinvertebrate density recovered to the near pre-alum level after the decline that was measured in 2006. Community structure also shifted, with the dominant group changing from oligochaetes before alum treatment to chaoborids in 2010. Chironomid density in 2010 was similar to pre-alum density, but this represented a decline from an elevated density measured in 2006. Ceratopogonid density increased in 2010 compared with the prior samplings, but absolute densities were very low compared with other macroinvertebrate groups. Maximum P release rates from sediment cores in 2010 averaged from 1.68 to 2.81 mg P m d under anoxic conditions. These rates are an order of magnitude lower than before alum was applied, indicating the alum application was still effectively reducing P release rates from sediments in Spring Lake. However, the release rates have increased since 2006, suggesting that alum efficacy may be declining. The NaOH-extractable soluble reactive P fraction has increased since 2006, suggesting that the aluminum hydroxide floc is successfully binding P in the sediments. Despite the low release rates of P from the sediment, water column P and chlorophyll concentrations remain elevated in Spring Lake. This points to the continued need for reductions in external P loads to Spring Lake.
Assuntos
Compostos de Alúmen/farmacologia , Organismos Aquáticos/efeitos dos fármacos , Recuperação e Remediação Ambiental , Invertebrados/efeitos dos fármacos , Fósforo/análise , Animais , Lagos/análise , MichiganRESUMO
The effectiveness of influenza vaccines is still controversial, and the role of adjuvants in such vaccines is briefly reviewed in this paper. Inactivated whole virus vaccines may include components that function as adjuvants, meaning that additive adjuvants are often not required. MF59 and AS03 showed higher adjuvanticity than aluminum salts in several clinical studies. Recent research has suggested that immune cell recruitment is the main mechanism underlying adjuvant actions in general, and that aluminum salts induce this recruitment via inflammation at the injected site. The aspect of how oil-based adjuvants, such as MF59 and AS03, recruit immune cells remains to be clarified.
Assuntos
Adjuvantes Imunológicos/farmacologia , Vacinas contra Influenza/imunologia , Compostos de Alúmen/farmacologia , Combinação de Medicamentos , Humanos , Polissorbatos/farmacologia , Esqualeno/farmacologia , Vacinas de Produtos Inativados/imunologia , alfa-Tocoferol/farmacologiaRESUMO
Alum is the principal vaccine adjuvant for clinical applications but it is a poor inducer of cellular immunity and is not an optimal adjuvant for vaccines where Th1 responses are required for protection. The mechanism underlying the inefficiency of alum in promoting Th1 responses is not fully understood. We show that aluminium hydroxide, aluminium phosphate, and calcium phosphate adjuvants inhibit the secretion of the Th1 polarizing cytokine, IL-12 by dendritic cells (DCs). Alum selectively inhibited DC expression of the IL-12p35 subunit and the inhibitory effect results from adjuvant-induced PI3 kinase signaling. To develop a more effective adjuvant for promoting cell-mediated immunity, we investigated alternative particulates and found that in contrast to alum, the cationic polysaccharide chitosan did not inhibit IL-12 secretion. A combination of chitosan and the TLR9 agonist CpG activated the NLRP3 inflammasome and enhanced secretion of IL-12 and the other key Th1 and Th17-cell polarizing cytokines. When used as an adjuvant, CpG-chitosan induced NLRP3-dependent antigen-specific Th1 and Th17 responses. A combination of alum and CpG also enhanced Th1 and Th17 responses but was less effective than CpG-chitosan. Therefore, chitosan is an attractive alternative to alum in adjuvants for vaccines where potent cell-mediated immunity is required.
Assuntos
Adjuvantes Imunológicos/farmacologia , Compostos de Alúmen/farmacologia , Células Dendríticas/imunologia , Subunidade p35 da Interleucina-12/metabolismo , Células Th1/imunologia , Células Th17/imunologia , Animais , Células Cultivadas , Quitosana/farmacologia , Células Dendríticas/efeitos dos fármacos , Feminino , Regulação da Expressão Gênica/imunologia , Imunidade Celular , Subunidade p35 da Interleucina-12/genética , Camundongos , Camundongos Endogâmicos C57BL , Fosfatidilinositol 3-Quinases/metabolismo , Transdução de Sinais/imunologiaRESUMO
CONTEXT: Alum is thought to induce inflammation resulting in the release of danger signals such as uric acid (UA) which in turn enhances the immune response to an antigen. Hydrogen peroxide (H(2)O(2)) is produced as a byproduct in the purine catabolic pathway that leads to the production of UA. In addition, serum nitric oxide (NO) levels are increased in inflammation. OBJECTIVE: To further explore the mechanism of action of alum, this study was designed to determine the effects of catalase and 1400W on the number of interleukin-4 (IL-4) and interferon-γ (IFN-γ) secreting spleen cells in mice given ovalbumin (OVA) with alum. MATERIALS AND METHODS: Groups of BALB/c mice were injected intraperitoneally with alum + OVA, alum, OVA, catalase, or 1400W. Other groups were treated with catalase or 1400W and given alum + OVA. The number of IL-4 and IFN-γ secreting spleen cells were determined at days 4 and 7 postinjection by enzyme-linked immunosorbent spot (ELISPOT). RESULTS: Catalase and 1400W caused a decrease in the number of IL-4 secreting spleen cells induced by alum + OVA. 1400W caused a decline in the IFN-γ secreting spleen cells induced by alum + OVA. Catalase caused an increase in IFN-γ secreting spleen cells. DISCUSSION AND CONCLUSION: It appears that H(2)O(2) and NO are needed for alum-induced production of a T-helper 2 cytokine. NO also appears to be needed, whereas H(2)O(2) appeared to inhibit an alum-induced production of a T-helper 1 cytokine. These results might explain why alum is mainly a promoter of a T-helper 2 response.
Assuntos
Adjuvantes Imunológicos/farmacologia , Compostos de Alúmen/farmacologia , Amidinas/farmacologia , Benzilaminas/farmacologia , Catalase/farmacologia , Inibidores Enzimáticos/farmacologia , Interferon gama/metabolismo , Interleucina-4/metabolismo , Ovalbumina/farmacologia , Baço/metabolismo , Animais , Bovinos , Contagem de Células , Feminino , Peróxido de Hidrogênio/imunologia , Peróxido de Hidrogênio/metabolismo , Interferon gama/imunologia , Interleucina-4/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Óxido Nítrico/imunologia , Óxido Nítrico/metabolismo , Baço/citologia , Baço/imunologiaRESUMO
The efficacy of a vaccine is generally dependent on an adjuvant, which enhances the immune functions and alum has been widely used in human immunization. Alum activates the intracellular stress sensors inflammasomes, but whether these are responsible for the adjuvanticity is controversial. The objectives of this investigation were to examine the hypothesis that alum-mediated adjuvanticity is a function of stress and conversely that stress agents will elicit adjuvanticity. The investigation was carried out in BALB/c mice by SC immunization with ovalbumin (OVA) mixed with alum. This elicited inflammasomes, with significant activation of caspase 1, production of IL-1ß, and adjuvanticity, demonstrated by enhancing OVA-specific serum IgG antibodies, CD4(+) T cells, and proliferation. The novel finding that alum induced HSP70 suggests that stress is involved in the mechanism of adjuvanticity. This was confirmed by inhibition studies with PES (phenylethynesulfonamide), which disrupts inducible HSP70 function, and inhibited both inflammasomes and the adjuvant function. Parallel studies were pursued with an oxidative agent (sodium arsenite), K-releasing agent (Gramicidin) and a metal ionophore (dithiocarbamate). All 3 stress agents induced HSP70, inflammasomes, and the adjuvant functions. Furthermore, up-regulation of membrane associated IL-15 on DC and CD40L on T cells in the animals treated with alum or the stress agents mediate the interactions between splenic CD11c DC and CD4(+) or CD8(+) T cells. The results suggest that the three stress agents elicit HSP70, a hallmark of stress, as well as inflammasomes and adjuvanticity, commensurate with those of alum, which may provide an alternative strategy in developing novel adjuvants.
Assuntos
Adjuvantes Imunológicos/farmacologia , Compostos de Alúmen/farmacologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Células Dendríticas/imunologia , Inflamassomos/imunologia , Estresse Fisiológico/efeitos dos fármacos , Animais , Antibacterianos/farmacologia , Arsenitos/farmacologia , Ligante de CD40/imunologia , Caspase 1/imunologia , Proliferação de Células/efeitos dos fármacos , Quelantes/farmacologia , Ditiocarb/farmacologia , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Gramicidina/farmacologia , Proteínas de Choque Térmico HSP70/imunologia , Humanos , Imunização/métodos , Imunoglobulina G/imunologia , Interleucina-15/metabolismo , Interleucina-1beta/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Ovalbumina/imunologia , Ovalbumina/farmacologia , Oxidantes/farmacologia , Compostos de Sódio/farmacologia , Estresse Fisiológico/imunologiaRESUMO
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases and key regulators for many physiological and pathological functions. The MMP inhibitors have been shown to modulate diseases such as cancer, inflammation, and cardiovascular diseases. In this paper we tracked the MMP inhibitory activities of the traditional Chinese medicinal herb Korean Monkshood Root. The purified active ingredient was identified by the elemental analysis, infrared spectrum (IR) and X-ray diffraction as aluminum ammonium sulfate dodecahydrate. This inorganic compound showed inhibitory activities toward a number of MMP family members. In particular, it has a strong inhibitory effect toward MMP-2 and MMP-9, with IC50 values of 0.54 and 0.50 µM, respectively. Further analysis suggested that the MMP inhibitory activity is mainly due to Al(3+). Cell viability assays using human fibrosarcoma HT1080 cells showed aluminum ammonium sulfate had minimal cyto-toxicity with a concentration up to 500 µM. However, within 50 µM, it exhibited significant inhibition of cell invasion. To our knowledge, there has been no previous report of inorganic form of the MMP inhibitor with strong inhibitory activity. Our results for the first time showed that aluminum ammonium sulfate is an inorganic form of MMP inhibitor with high potency, and can be used to interfere with MMP related cellular processes.
Assuntos
Compostos de Alúmen/química , Compostos de Alúmen/farmacologia , Medicamentos de Ervas Chinesas/química , Medicamentos de Ervas Chinesas/farmacologia , Inibidores Enzimáticos/farmacologia , Inibidores de Metaloproteinases de Matriz , Plantas Medicinais/química , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Inibidores Enzimáticos/química , Humanos , Difração de Raios XRESUMO
Influenza A/H3N2 viruses have caused the most severe epidemics since 1968 despite current immunization programs with inactivated vaccines. We undertook a side-by-side preclinical evaluation of different adjuvants (Alum, AS03, and Protollin) and routes of administration (intramuscular [i.m.] and intranasal [i.n.]) for assessing their effect on the immunogenicity and cross-reactivity of inactivated split vaccines (A/H3N2/New York/55/2004). Humoral and T cell-mediated immune responses against the homologous virus and a heterologous drifted strain (A/H3N2/Wisconsin/67/2005) were measured in BALB/c mice at 2, 6, and 19 weeks postboost. The AS03- and Alum-adjuvanted i.m. vaccines induced at least an 8-fold increase over the nonadjuvanted vaccine in functional antibody titers against both the homotypic and heterotypic strains and low IgG2a and high IgG1 levels, suggesting a mixed Th1/Th2 response with a Th2 trend. The Protollin-adjuvanted i.n. vaccine induced the lowest IgG1/IgG2a ratio, which is indicative of a mixed Th1/Th2-type profile with a Th1 trend. This adjuvanted vaccine was the only vaccine to stimulate a mucosal IgA response. Whatever the timing after the boost, both hemagglutination inhibition (HAI) and microneutralization (MN) titers were higher with the AS03-adjuvanted i.m. vaccine than with the protollin-adjuvanted i.n. vaccine. Finally, the Alum-adjuvanted i.m. vaccine and the lower-dose Protollin-adjuvanted i.n. vaccine elicited significantly higher CD4(+) Th1 and Th2 responses and more gamma interferon (IFN-γ)-producing CD8(+) T cells than the nonadjuvanted vaccine. Our data indicate that the adjuvanted vaccines tested in this study can elicit stronger, more persistent, and broader immune responses against A/H3N2 strains than nonadjuvanted inactivated influenza vaccines.
Assuntos
Adjuvantes Imunológicos/farmacologia , Vírus da Influenza A Subtipo H3N2/imunologia , Vacinas contra Influenza/imunologia , Infecções por Orthomyxoviridae/prevenção & controle , Adjuvantes Imunológicos/administração & dosagem , Administração Intranasal , Compostos de Alúmen/administração & dosagem , Compostos de Alúmen/farmacologia , Animais , Anticorpos Antivirais/imunologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Cisteína Endopeptidases/administração & dosagem , Cisteína Endopeptidases/imunologia , Combinação de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Testes de Inibição da Hemaglutinação , Imunidade Celular , Imunidade Humoral , Imunoglobulina A/imunologia , Imunoglobulina G/imunologia , Vacinas contra Influenza/administração & dosagem , Injeções Intramusculares , Interferon gama/imunologia , Lipopolissacarídeos/administração & dosagem , Lipopolissacarídeos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Infecções por Orthomyxoviridae/imunologia , Células Th1/imunologia , Células Th2/imunologia , Vacinação/métodosRESUMO
Five saponins purified from the leaves of three Ilex species (saponins 1 and 2 from I. dumosa; saponin 3 from I. argentina; saponin 4 from I. paraguariensis) and from Passiflora alata (saponin 5) were evaluated for their in vitro haemolytic activity and in vivo immunostimulatory ability in a mouse model using tetanus toxoid (TT) as a model antigen. The assayed saponins showed very weak or no haemolytic activity over the tested concentration range. Mice were immunized twice with TT formulated with pure saponins 1-5, or with a mixture of saponins from Quillaja saponaria, aluminum hydroxide gel or saline, which were used as controls. The elicited humoral response was evaluated by means of the time course of specific serum antibody levels up to day 131 post-priming (total IgG and isotypes); the cellular response was tested through a delayed-type hypersensitivity (DTH) assay. The assayed saponins, in particular saponins 3 and 5, showed an adjuvant effect similar to that of alum for all tested parameters. The immunostimulating potential of these compounds deserves further investigation, especially taking into account that some Ilex spp. and Passiflora alata are native crops of widespread use and economical importance in Latin America.
Assuntos
Adjuvantes Imunológicos/farmacologia , Ilex/química , Passiflora/química , Saponinas/imunologia , Compostos de Alúmen/farmacologia , Animais , Hemólise , Hipersensibilidade Tardia/imunologia , Imunidade Celular , Imunidade Humoral , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Quillaja/química , Saponinas/farmacologia , Toxoide TetânicoRESUMO
Vaccine adjuvants target the innate immune system to enhance the immunogenicity of coadministered antigens. Dendritic cells (DCs) are responsible for antigen uptake and presentation to naïve T cells and represent a key target of adjuvant activity. Adjuvants derived from microbial components, such as Toll-like receptor (TLR) agonists, elicit innate immune receptors expressed by DCs. By contrast, particulate adjuvants, like mineral salts, oil-in-water emulsions, and microparticles, do not activate DCs directly, and their mechanism of action is poorly characterized. In the last two years it has been reported that particulate adjuvants induce chemokine production in accessory cells like macrophages, monocytes, and granulocytes, leading to cell recruitment at injection site followed by the differentiation of monocytes into activated DCs. The NLRP3 inflammasome complex is one of the molecular targets of particulate adjuvants and it is required for alum adjuvanticity. Other TLR-independent adjuvants were found to target DCs directly or by other accessory cells like iNKT or mast cells. These findings highlight that the activation of DCs plays a central role in the mechanism of action of all classes of vaccine adjuvants but can occur by a multitude of different pathways and cellular interactions.
Assuntos
Adjuvantes Imunológicos/farmacologia , Células Dendríticas/efeitos dos fármacos , Receptores Toll-Like/metabolismo , Compostos de Alúmen/farmacologia , Animais , Proteínas de Transporte/metabolismo , Células Dendríticas/imunologia , Células Dendríticas/metabolismo , Humanos , Imunidade Inata/efeitos dos fármacos , Imunidade Inata/imunologia , Proteína 3 que Contém Domínio de Pirina da Família NLRRESUMO
Hydroxyapatite (HA) has been extensively investigated as scaffolds for tissue engineering, as drug delivery agents, as non-viral gene carriers, as prosthetic coatings, and composites. Recent studies in our laboratory demonstrated the immunoadjuvant properties of HA when administered with malarial merozoite surface protein-1(19) (MSP-1(19)). HA nanoceramic carrier was prepared by co-precipitation method that comprises of sintering and spray-drying technique. Prepared systems were characterized for crystallinity, size, shape, and antigen loading efficiency. Small size and large surface area of prepared HA demonstrated good adsorption efficiency of immunogens. Prepared nanoceramic formulations also showed slower in vitro antigen release and slower biodegrability behavior, which may lead to a prolonged exposure to antigen-presenting cells and lymphocytes. Furthermore, addition of mannose in nanoceramic formulation may additionally lead to increased stability and immunological reactions. Immunization with MSP-1(19) in nanoceramic-based adjuvant systems induced a vigorous immunoglobulin G (IgG) response, with higher IgG2a than IgG1 titers. In addition considerable amount of IFN-g and IL-2 was observed in spleen cells of mice immunized with nanoceramic-based vaccines. On the contrary, mice immunized with MSP-1(19) alone or with alum did not exhibit a significant cytotoxic response. The antibody responses to vaccine co-administered with HA was a mixed Th1/Th2 compared to the Th2-biased response obtained with alum. The prepared HA nanoparticles exhibit physicochemical properties that appear promising to make them a suitable immunoadjuvant to be used as antigen carriers for immunopotentiation.
Assuntos
Durapatita/química , Vacinas Antimaláricas/administração & dosagem , Proteína 1 de Superfície de Merozoito/imunologia , Nanopartículas/química , Plasmodium/imunologia , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/química , Adjuvantes Imunológicos/farmacologia , Adsorção , Compostos de Alúmen/administração & dosagem , Compostos de Alúmen/química , Compostos de Alúmen/farmacologia , Animais , Formação de Anticorpos , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/química , Durapatita/administração & dosagem , Durapatita/imunologia , Feminino , Imunoglobulina G/imunologia , Vacinas Antimaláricas/química , Vacinas Antimaláricas/imunologia , Manose/administração & dosagem , Manose/química , Manose/imunologia , Proteína 1 de Superfície de Merozoito/administração & dosagem , Proteína 1 de Superfície de Merozoito/química , Camundongos , Camundongos Endogâmicos BALB C , Nanopartículas/ultraestrutura , Células Th1/imunologia , Células Th2/imunologiaRESUMO
Fluoride toxicity is a serious health problem in many parts of the globe. In present study, sodium fluoride at 20 mg/kg alone and in conjunction with aluminum sulfate at 150 mg/kg was administered orally daily for 30 days in healthy goats of group 1 and 2, respectively, to access the alterations in the various biochemical parameters during subacute toxicity of fluoride alone and in conjunction with aluminum sulfate. In Group 1, significant alterations in plasma glucose, blood urea nitrogen (BUN), creatinine, total protein, albumin, globulin, albumin/globulin ratio, magnesium, and sodium were observed on different days of exposure from their pre-exposure values. However, no significant changes were observed in plasma calcium, phosphorus, and potassium on different days of exposure of sodium fluoride. Similar type of biochemical alterations were noticed in the goats of Group 2 except BUN, total protein magnesium, and sodium. On the basis of results, it could be concluded that sodium fluoride alone and in conjunction with aluminum sulfate produced significant alterations in the various biochemical parameters of the body.
Assuntos
Adjuvantes Imunológicos/farmacologia , Compostos de Alúmen/farmacologia , Cabras/fisiologia , Fluoreto de Sódio/toxicidade , Animais , Glicemia/efeitos dos fármacos , Nitrogênio da Ureia Sanguínea , Cálcio/metabolismo , Creatinina/metabolismo , Magnésio/metabolismo , Sódio/metabolismoRESUMO
Adjuvants are vaccine additives that stimulate the immune system without having any specific antigenic effect of itself. In this study we show that alum adjuvant induces the release of IL-1beta from macrophages and dendritic cells and that this is abrogated in cells lacking various NALP3 inflammasome components. The NALP3 inflammasome is also required in vivo for the innate immune response to OVA in alum. The early production of IL-1beta and the influx of inflammatory cells into the peritoneal cavity is strongly reduced in NALP3-deficient mice. The activation of adaptive cellular immunity to OVA-alum is initiated by monocytic dendritic cell precursors that induce the expansion of Ag-specific T cells in a NALP3-dependent way. We propose that, in addition to TLR stimulators, agonists of the NALP3 inflammasome should also be considered as vaccine adjuvants.